- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05462158
Message Testing for CKD
February 9, 2023 updated by: University of Pennsylvania
The Impact on Nudges of CKD Testing
Members of CVS/Aetna will receive one of two text messages or receive no text message at all.
In the available for members condition, participants will receive a text message that says, "Two common kidney tests have been made available for members.
By taking them, you could stay ahead of any problems and keep enjoying life.
Schedule a doctor visit today to ask about them."
In the Checked Health condition, the message will say, "Have you checked your kidney health recently?
By taking two common kidney tests, members can stay ahead of any problems and keep enjoying life.
Schedule a doctor visit today to ask about them."
There will also be a group of members that do not receive a text message at all.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The investigators will examine the proportion of participants that book an appointment, proportion of new diagnoses for CKD, creatinine tests and/or albuminuria tests, proportion of participants that looked for more information after receiving the text message.
The investigators will examine these metrics 6 months after all of the text messages have gone out ~8,637.
The investigators will examine difference in conditions between the metrics listed above in the DV section.
The investigators will compare the two conditions to each other, as well as to the group who does not receive a text message.
The investigators will conduct a series of chi square tests/logistic regressions to examine the differences.
Study Type
Interventional
Enrollment (Actual)
8637
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Center for Health Incentives and Behavioral Economics (CHIBE)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participant must be a health insurance customer with the company we are working with.
- All other eligibility criteria are determined by the company and not disclosed to us. They will pick a sample of customers for the study, with participants then being randomly assigned to treatments they qualify for.
Exclusion Criteria:
- NA
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Available for Members-Text
Participants will receive a text message that says, "Two common kidney tests have been made available for members.
By taking them, you could stay ahead of any problems and keep enjoying life.
Schedule a doctor visit today to ask about them.
|
The investigators will examine the impact of different messages on different dimensions of testing for CKD
|
|
EXPERIMENTAL: Checked Health-Text
Participants will receive a text message that will say, "Have you checked your kidney health recently?
By taking two common kidney tests, members can stay ahead of any problems and keep enjoying life.
Schedule a doctor visit today to ask about them."
|
The investigators will examine the impact of different messages on different dimensions of testing for CKD
|
|
EXPERIMENTAL: No Text Message
Participants in this group will not receive a text message at all
|
The investigators will examine the impact of different messages on different dimensions of testing for CKD
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of appointments
Time Frame: The investigators will examine this 6 months after all of the text messages are sent out~8637 of them
|
The investigators will examine the proportion of appointments participants make between conditions
|
The investigators will examine this 6 months after all of the text messages are sent out~8637 of them
|
|
Proportion of new diagnoses for CKD, creatinine tests and/or albuminuria tests
Time Frame: The investigators will examine this 6 months after all of the text messages are sent out~8637 of them
|
The investigators will examine this 6 months after all of the text messages are sent out~8637 of them
|
|
|
Proportion of participants that looked for more information
Time Frame: The investigators will examine this 6 months after all of the text messages are sent out~8637 of them
|
Participants can request for more information upon receiving the text message
|
The investigators will examine this 6 months after all of the text messages are sent out~8637 of them
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marissa Sharif, PhD, University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 15, 2022
Primary Completion (ACTUAL)
September 15, 2022
Study Completion (ACTUAL)
December 15, 2022
Study Registration Dates
First Submitted
April 24, 2022
First Submitted That Met QC Criteria
July 15, 2022
First Posted (ACTUAL)
July 18, 2022
Study Record Updates
Last Update Posted (ACTUAL)
February 13, 2023
Last Update Submitted That Met QC Criteria
February 9, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 850936
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The company we are working with will be analyzing the data and informing us of the results.
We will not have data to share.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Available for Members Text Message
-
Harvard School of Public Health (HSPH)Health Science Center of Xi'an Jiaotong UniversityCompletedText Messaging | Short Message ServiceChina
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedPatients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is AvailableUnited States
-
ProMedica Health SystemCompletedFocus: to Compare a Commercially Available Energy Drink, B Vitamins, Caffeine Alone, and Placebo for Effectiveness on Perceived Energy Level and WakefulnessUnited States
-
João Firmino Domingues Barbosa MachadoUniversidade do PortoCompletedReminder Systems | Uterine Cervical Neoplasm | Mass Screening | Early Detection of Cancer | Text MessagePortugal
-
Caritas Institute of Higher EducationUnknownMessage-based Rehabilitation for Peripheral Artery Disease PatientsChina, Hong Kong
-
Nordsjaellands HospitalUniversitaire Ziekenhuizen KU Leuven; Hillerod Hospital, DenmarkCompletedPostoperative Pain | Cesarean Section | Pain Management | Cohort Study | Cesarean Delivery | Wound Infiltration | Patient Reported Outcome | Text Message | Pain Management in Postoperative CareDenmark
-
Charite University, Berlin, GermanyUniversity of LeipzigUnknownAcute Myeloid Leukemias | Advanced Hematological Malignancies | Indication for Allogeneic Stem Cell Transplantation | no HLA-identical Donor AvailableGermany
-
University of Sao PauloSantanderTerminatedEar Acupuncture Effectiveness In Reducing The Signs And Symptoms Of Stress And Anxiety (EAEIRTSOSAA)Inclusion Criteria: | Voluntary Participation in the Study With Available Time for Submission to the Sessions, Which Occur Over Two Months. | Have a Score of Stress Medium, High or Very High in the LSS Questionnaire, Completion of the STAI and General Form. | Exclusion Criteria: | Pregnant...
-
Ankara UniversityCompletedEvaluation of the Effects of Education Provided on Family Members Caring for Colorectal Cancer PatientsTurkey
-
International Centre for Diarrhoeal Disease Research...University of California, Berkeley; University of Maryland; Harvard UniversityCompletedDevelop a New Group Version of the Becker-DeGroot-Marsckek (BDM) Auction to Measure Willingness to Pay of Compound Members for Shared Hardware. | Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social... and other conditionsBangladesh
Clinical Trials on Impact of Nudges on CKD Testing
-
Meir Medical CenterCompletedObesity | Obesity, Childhood | Tendon ThickeningIsrael
-
Population CouncilAlbert Einstein College of Medicine; Emory UniversityCompleted
-
Kathmandu University School of Medical SciencesNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisUnknown
-
University of ChesterCompletedMenopause | Metabolic Syndrome, Protection AgainstUnited Kingdom
-
University of PaviaIRCCS ISTITUTO NEUROLOGICO CASIMIRO MONDINORecruitingEpilepsy | Drug Resistant Epilepsy | Ketogenic Dieting | GLUT1DS1 | Menstrual EpilepsyItaly
-
University of TorontoUniversity Health Network, Toronto; The Physicians' Services Incorporated FoundationUnknownRespiratory Distress Syndrome, AdultCanada
-
Universidad de CórdobaInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)RecruitingBody Weight | Musculoskeletal Diseases | DyslipidemiasSpain
-
Minia UniversityCompletedObesity During Pregnancy in Clinical PracticeEgypt
-
Hospices Civils de LyonRecruiting